| Financial Year |
March 31 2023 |
| Monetary Funds |
41,773,928.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
43,324,033.91 |
| Accounts Receivable |
295,210,870.49 |
| Advances to Suppliers |
257,099,326.68 |
| Other Receivables |
470,621,869.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,312,908,094.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
65,328,312.86 |
| Total Current Assets |
3,486,266,436.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
305,961,332.98 |
| Investment Properties |
102,132,773.16 |
| Fixed Assetes |
2,006,427,570.75 |
| Under-construction Projects |
56,044,626.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
3,954,793.94 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
269,886,104.93 |
| R&D expenses |
-- |
| Goodwill |
21,463,728.33 |
| Long-Term Deferred and Prepaid Expenses |
34,623,970.67 |
| Deferred Income Tax Assets |
15,892,711.45 |
| Other Non-Current Assets |
39,525,515.26 |
| Sub-Total of Non-Current Assets |
2,863,142,331.04 |
| Total Assets |
6,349,408,767.85 |
| Short-Term Loans |
824,021,270.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
502,443,635.77 |
| Accounts Received In Advance |
12,873,722.14 |
| Employee Compensation Payable |
11,450,620.61 |
| Taxes Payable |
39,081,402.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
130,619,211.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
68,622,473.30 |
| Other Current Liabilities |
64,614,613.95 |
| Sub-Total of Current Liabilities |
1,749,316,772.37 |
| Long-term Loans |
4,244,747.09 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
893,858,604.79 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
758,246.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
933,951,076.94 |
| Total Liabilities |
2,683,267,849.31 |
| Paid-In Capital(Or Share Stock) |
766,773,200.00 |
| Capital Surplus |
2,934,531,398.48 |
| Surplus Reserve |
102,084,065.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-254,482,770.44 |
| Minority Stockholder's Interest |
111,598,904.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,554,542,013.88 |
| Owner's Equity（Stockholder's Equity） |
3,666,140,918.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,349,408,767.85 |
